Compound class:
Antibody
Comment: CMTX-101 is a humanized monoclonal antibody against members of the DNABII family of bacterial DNA-binding proteins [1]. It disrupts bacterial biofilms and is being developed by Clarametyx Biosciences (Ohio, USA) as an immune-mediated therapy for serious infections associated with biofilms.
|
Bioactivity Comments |
By targeting a universal component of bacterial biofilms, CMTX-101 enhances the efficacy of antibacterial agents against both Gram-positive and Gram-negative bacteria [1]. |